EP3354729 - Bibliographic data
ANTICORPS ANTAGONISTE DE PRÉDOMINANCE DE RÉPÉTITIONS DE GLYCOPROTÉINE-A (GARP)
| Last update | 18/06/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
Daiichi Sankyo Company, Limited 3-5-1 Nihonbashi-honcho
Chuo-ku
Tokyo 103-8426
Japon
|
|---|---|
| (72) Inventors |
Kazuki SATOH c/o DAIICHI SANKYO COMPANY, LIMITED
3-5-1 Nihonbashi Honcho
Chuo-ku
Tokyo 103-8426
Japon
Kazuki HIRAHARA c/o DAIICHI SANKYO COMPANY, LIMITED
3-5-1 Nihonbashi Honcho
Chuo-ku
Tokyo 103-8426
Japon
Ichiro WATANABE c/o DAIICHI SANKYO COMPANY, LIMITED
3-5-1 Nihonbashi Honcho
Chuo-ku
Tokyo 103-8426
Japon
Masato AMANO c/o DAIICHI SANKYO COMPANY, LIMITED
3-5-1 Nihonbashi Honcho
Chuo-ku
Tokyo 103-8426
Japon
|
| (74) Agent |
Mail recipient
MARKS & CLERK LLP 44, Rue de la Vallée - BP 1775
1017
LUXEMBOURG
Luxembourg
|
| (21) Request number | EP16848676.9 |
|---|---|
| (22) Request date | 23/09/2016 |
| (11) Publication number | EP3354729 |
|---|---|
| Publication date | 14/02/2024 |
| (54) Title of the invention | ANTICORPS ANTAGONISTE DE PRÉDOMINANCE DE RÉPÉTITIONS DE GLYCOPROTÉINE-A (GARP) |
|---|---|
| (51) International classification | C12N 15/02, A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/32, C12N 1/15, C12N 1/19, C12N 1/20, C12N 5/10, C12P 21/08, A61K 39/00 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 2015187488 |
|---|---|
| Initial application | None |
| Divisional application | EP24157462.3 /EP4349997 None |
| Expected annuity | Annuity: 10 - Amount: 195 € - Due date 30/09/2025 |
|---|---|
| Last annuity | Annuity: 9 - Payment date 23/09/2024 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 14/02/2024 Constitution de mandataire pour un dossier - Legal date 18/03/2024 |